Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Chronic myeloid leukaemia (CML), Hodgkin lymphoma, Leukaemia, Myelodysplastic syndrome (MDS), Myelofibrosis, Myeloma, Non-Hodgkin lymphoma (NHL)
Open
Phase 2
This trial is comparing with 2 newer combinations of treatment to prevent graft versus host disease (GvHD).
It is for people having a stem cell transplant for certain types of blood cancer.
Recruitment start: 22 February 2021
Recruitment end: 31 January 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ronjon Chakraverty
University of Birmingham
IMPACT Partnership
Last reviewed: 13 March 2025
CRUK internal database number: 18058
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
